Document Detail

New progress of non-surgical treatments for hepatocellular carcinoma.
MedLine Citation:
PMID:  23292867     Owner:  NLM     Status:  In-Data-Review    
Many non-surgical treatments of hepatocellular carcinoma (HCC) have significantly improved in the last few decades and have shown survival benefits for selected patients with HCC. Today ablation can improve survival in individuals diagnosed in early HCC and even offer a curative treatment in selected candidates. Patients with intermediate-stage HCC benefit from transarterial chemoembolization (TACE). Drug-eluting bead transarterial chemoembolization (DEB-TACE) has shown a better combined ischemic and cytotoxic effect locally and less system toxicity when compared with conventional TACE. Those diagnosed at advanced stage benefit from sorafenib. In addition to TACE and sorafenib which could improve survival for selected patients, three-dimensional conformal radiotherapy treatment (3-DCRT), selection internal radiation therapy and systemic chemotherapy have also shown anti-tumor activity in the treatment of advanced HCC, but their survival benefit have not been proven. The limited effects of single therapy suggested that the combination would enhance the overall treatment effect. Other potential non-surgical therapies like gene therapy and immunotherapy are still in testing phases, except for some small-scale clinical trials which have been reported to show some beneficial effect. Here, we review the current non-surgical treatments in HCC and the new advances in this field.
Ji-Wen Cheng; Yi Lv
Related Documents :
9508167 - High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of sur...
20696827 - Survival defects of cryptococcus neoformans mutants exposed to human cerebrospinal flui...
7540147 - Priming and treatment with molgramostim (rhgm-csf) in adult high-risk acute myeloid leu...
2185337 - Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic ...
16285617 - Transrectal high-intensity focused ultrasound in the treatment of localized prostate ca...
21458087 - Radiographic and metabolic response rates following image-guided stereotactic radiother...
Publication Detail:
Type:  Journal Article     Date:  2013-01-06
Journal Detail:
Title:  Medical oncology (Northwood, London, England)     Volume:  30     ISSN:  1559-131X     ISO Abbreviation:  Med. Oncol.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-01-07     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9435512     Medline TA:  Med Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  381     Citation Subset:  IM    
Department of Hepatobiliary Surgery, First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, 76 Yanta West Road, Xi'an, 710061, People's Republic of China,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Aberrant expression of miR-199a-3p and its clinical significance in colorectal cancers.
Next Document:  A PML/RARA chimeric gene on chromosome 12 in a patient with acute promyelocytic leukemia (M4) associ...